Tata Chemicals Q2 FY27: Sales Rose 7.7%, So Why Did Margins and Profit Fall?

Event and reporting period: Q2 FY27, quarter ended 30 September 2026; November investor presentation · Analysis checked: 9 November 2026.

Tata Chemicals sold more in rupee terms during Q2 FY27, yet its operating earnings declined. Consolidated revenue increased to ₹4,177 crore from ₹3,877 crore a year earlier. EBITDA fell to ₹381 crore from ₹537 crore. That gap is the central story: higher sales did not translate into a higher pool of operating profit.

There is a second trap in the presentation. Its headline PAT measure is a ₹50 crore loss, but that measure is before exceptional items and before non-controlling interests, after the stated joint-venture and associate adjustment. The detailed financial summary shows a ₹122 crore loss after exceptional items and non-controlling interests. Calling both simply “net loss” loses information readers need.

Sales growth and profit growth went opposite ways

Source: Tata Chemicals — Q2 FY27 investor presentation, PDF pp.4–5, 7 and 13.

Year-on-year sales growth was 7.74%, but EBITDA declined 29.05%. The calculated operating margin fell by 4.73 percentage points. This is a change from approximately ₹13.85 of EBITDA per ₹100 of revenue to ₹9.12. It is not a 4.73% relative decline; the unit is percentage points.

The sequential comparison is weaker too. Revenue fell 1.83% from Q1 and EBITDA declined 31.35%. A single positive sales-growth headline therefore misses both the margin pressure and the deterioration relative to the immediately preceding quarter. Seasonal patterns still matter, so neither comparison should stand alone.

The company's EBITDA bridge gives the explanation

The presentation attributes the movement from ₹537 crore to ₹381 crore to three effects: positive ₹72 crore from volume and mix, negative ₹129 crore from pricing, and negative ₹99 crore from fixed costs. These sum exactly: 537 + 72 − 129 − 99 = 381.

This bridge is more useful than a vague statement that demand was weak. Better volume and mix contributed, but pricing and fixed-cost effects more than absorbed that benefit. The combined negative effects were ₹228 crore, against ₹72 crore of support. There was ₹3.17 of adverse effect for each ₹1 of positive volume-and-mix contribution.

That does not mean every product price fell. The revenue bridge and the EBITDA bridge measure different effects and can use different bases. Revenue can benefit from mix or particular prices while profitability is pressured elsewhere. One should use the company's stated bridge labels rather than combine selected pieces into an unsupported explanation.

The ₹50 crore and ₹122 crore losses are not interchangeable

Page 13 is the important cross-check. The ₹122 crore loss includes the exceptional-item and non-controlling-interest treatment excluded from the presentation's headline ₹50 crore loss. A comparison with the prior-year ₹77 crore figure must use the same after-exceptional, after-NCI definition.

Using ₹50 crore for the current quarter and ₹77 crore for the previous year would compare two different profit measures. The same problem occurs when standalone PAT is substituted for consolidated PAT because it looks more attractive. Definition discipline matters most when a business is near break-even, because modest adjustments can change the sign of the result.

This article does not label the entire difference as cash loss or infer an undisclosed impairment. The financial notes determine the components. The correct first step is to identify which profit belongs to which definition before deciding what should recur in a valuation model.

Standalone strength cannot cancel the overseas question

The India standalone business reported revenue of ₹1,303 crore and EBITDA of ₹292 crore. Dividing these gives an EBITDA margin of about 22.41%. Consolidated margin was 9.12%. The gap demonstrates why the standalone business is not an adequate proxy for the full group.

The presentation discusses oversupply and difficult industrial demand, unremunerative pricing in certain export markets, energy and logistics pressures in the UK, and a temporary suspension in Kenya. These are management explanations, not independently quantified forecasts. The useful task is to see whether later segment disclosures and operating cash flows show improvement in those areas.

Segment revenue and profit lines should not be added casually to reconstruct the group. Consolidation adjustments, inter-company transactions and different reporting definitions can intervene. The consolidated financial summary is the anchor for the totals used in this article.

Debt needs the same lease treatment on both dates

External net debt was ₹6,127 crore at September 2026, compared with ₹5,961 crore at March 2026, excluding leases. That is an increase of ₹166 crore, or 2.78%. Disclosed lease liabilities were ₹840 crore and ₹887 crore respectively.

Adding those disclosed lease figures to the corresponding external-net-debt figures gives analytical totals of ₹6,967 crore and ₹6,848 crore, a ₹119 crore increase. These sums are our calculation, not a relabelling of the company's stated net-debt definition. Comparing one date including leases with the other excluding them would exaggerate or understate the change.

A higher debt balance alongside lower operating earnings deserves monitoring, but it is not enough to predict a financing problem. Maturities, liquidity, committed facilities, capital spending and cash conversion are needed. We do not annualise this weak quarter into a permanent earnings forecast or infer a credit rating change.

What would count as evidence of a turnaround?

Look for a narrowing price-and-cost gap in the next EBITDA bridge, improved profitability in the pressured overseas units, and cash generation after investment spending. Revenue growth alone is insufficient. A price recovery without better cash conversion may tell a different story from a broad improvement in operating economics.

For a fund holder, the relevant question is how much exposure the portfolio actually carries and whether that exposure is repeated across schemes. A diversified fund can hold a cyclical chemical business without being a chemical-sector fund. The latest disclosed weight and the manager's mandate are more useful than assuming every shareholder has the same risk tolerance.

Questions readers ask

Did Tata Chemicals revenue fall year on year?

No. It increased 7.74% from the rounded figures, while EBITDA fell 29.05%. The calculated EBITDA margin declined from 13.85% to 9.12%.

Which loss includes exceptional items and non-controlling interests?

The ₹122 crore consolidated loss shown in the detailed financial summary. The ₹50 crore loss is a differently defined presentation measure.

Is the debt-plus-leases total an official net-debt measure?

No. It is an explicitly identified sum of disclosed components. The company’s external-net-debt figure excludes leases.

Connect the event to your own funds

Use MF Analyser research to check the relevant scheme, its disclosed holdings and the date of that disclosure. A company or policy headline reaches a portfolio through its actual positions and weights. Several funds can repeat the same underlying exposure, so count the combined position before treating the headline as a reason to change investments.